Written Question·Department of Health and Social Care·UIN 12371
Vorasidenib
Tabled: 4 November 2024
Answered: 11 November 2024
Question
Andrew Rosindell
Reform UK — Romford
To ask the Secretary of State for Health and Social Care, whether the MHRA is considering the approval of vorasidenib for the treatment of low grade gliomas.
Answer
Karin SmythIt is critical that medicines used in the United Kingdom are safe and effective and as such, medicines cannot be marketed in the UK without a marketing authorisation. These are granted by the Medicines and Healthcare products Regulatory Agency (MHRA) whic...
ⓘ
This is an extract from the Parliament API. Search the full answer on Parliament.uk (UIN 12371) →